Heart Disease Journals

Cardiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Larrayoz IM et al. – The authors hypothesize that the anti–inflammatory effects of candesartan in these cells are likely mediated by mechanisms unrelated to AT1 receptor blockade. The results demonstrate that candesartan significantly reduces the innate immune response to LPS in human circulating monocytes. The anti–inflammatory effects of candesartan may be of importance not only in hypertension but also in other inflammatory disorders.


Today in Atherosclerosis/Lipids...keeping you current

Antiplatelet Agents in Acute Coronary Syndromes
Current Problems in Cardiology, 02/09/10

Hyperlipidemia and Reduced White Matter Hyperintensity Volume in Patients With Ischemic Stroke
Stroke, 02/09/10

Altered cholesterol and fatty acid metabolism in Huntington disease
Journal of Clinical Lipidology, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address